References
[1] Sun, Z. H., Zhang, J. L., Cui, Z. Y., et al. (2019). A study on the epidemiology of common anorectal diseases in adults in Shanxi Province [J]. China Drugs & Clinics, 2019, 19(14): 2363-2365.
[2] Dai, H. L., Dong, C., Xu, L., et al. (2017). Research progress of anal fissures and their treatment methods [J]. China Prescription Drugs, 2017, 15(07): 20-21.
[3] Guo, J. P., Xia, Q., Deng, W. L., et al. (2020). Study on the mechanism of the action of Sophora flavescens in the treatment of ulcerative colitis with passing of bloody stool [J]. Modern Chinese Medicine, 2020, 40(05): 9-14+21.
[4] Sun, S. H.,Wang, X. L., Li, Z. F., et al. (2015). A brief study on the treatment of hemorrhagic anorectal diseases with Sophora pinnata [J]. Journal of Practical Chinese Medicine Internal Medicine, 2015, 29(12): 179-181.
[5] Ru, J. L., Li, P., Wang, J. N., et al. (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminformatics, 2014 Apr 16, 6(1): 13.
[6] Ahmed, S. S., Ramakrishnan, V. (2012). Systems biological approach of molecular descriptors conectivity: Optimal descriptors for oral bioavailability prediction [J]. PLoS One, 2012, 7(7): e40654.
[7] Mochizuki, M., Suzuki, S. D., Yanagisawa, K., et al. (2019). QEX: target-specific druglikeness. Liu Z, Guo F, Wang Y, et al. BATMAN-TCM: A Bioinformatics Analysis Tool for Molecular mechanism of Traditional Chinese Medicine. Sci Rep., 2016, 6: 21146. Filter enhances ligand-based virtual screening [J]. Mol Divers, 2019, 23(1): 11-18.
[8] Jia, J. J., Miao, M. S. (2014). Chemistry, pharmacology and clinical applications of Sophora japonica [J]. Journal of Traditional Chinese Medicine, 2014, 29(05): 716-717+745.
[9] Zhao, Y., Guo, J., Liu, T., et al. (2010). Pharmacological studies on the new haemostatic components of Sophora japonica after charcoal making [J]. Chinese Journal of Traditional Chinese Medicine, 2010, 35(17): 2346-2349.
[10] Du, H. X. (2013). Research progress on the active ingredients of Phellodendron sylvestris [J]. Guangdong Chemical Industry, 2013, 40(20): 150-151.
[11] Gong, B., Li, Q., Hu, X. H., et al. (2019). Research progress on chemical composition and pharmacological effects of Citrus aurantium [J]. Southern Forestry Science, 2019, 47(03): 40-45.
[12] Chen, H., Gao Meng, Luo, X. Q., et al. (2019). Principal component analysis and discriminant analysis of 12 active ingredients in Citrus aurantium herbs from different origins [J]. Chinese Herbal Medicine, 2019, 50(14): 3433-3437.
[13] Zhang, G. X. (2011). Chemical composition, pharmacological effects and clinical applications of Erythrina bark [J]. Journal of Shanxi Staff Medical College, 2011, 21(01): 57-58.
[14] Wang, X., Shen, Y. L., Wang, S. W., et al. (2017). PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res., 2017, 45, W356-W360.
[15] Morgat, A., Lombardot, T., Coudert, E., et al. (2019). UniProt Consortium. Enzyme annotation in UniProtKB using Rhea Bio-informatics, 36(6): 1896-1901.
[16] Huang, D. W., Sherman, B. T., Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc., 2009, 4(1): 44-57.
[17] Zhang, X. M., Wang, Y. Y., Wang, H. J. (2020). Research progress of flavonoids in Chinese herbal medicines [J]. Guangdong Chemical Industry, 2020, 47(24): 55-56.
[18] Zhong, Y. K., Wu Di, Hua, X. D., et al. (2019). Advances in the research on the antibacterial effects of flavonoids [J]. China Food Additives, 2019, 30(08): 166-171.
[19] Li, C. X., Yang, Y. H., Leng, D. S., et al. (2019). Research progress on chemical composition and pharmacological effects of Citrus aurantium [J]. Journal of Liaoning University of Chinese Medicine, 2019, 21(02): 158-161.
[20] Liu, X. D., Cai, F., Liu, L., et al. (2015). MicroRNA-210 is involved in the regulation of postmenopausal osteoporosis through promotion of VEGF expression and osteoblast differentiation [J]. Biological Chemistry, 2015, 396(4).
[21] Liang, T., Qin, Y. M., Ding, H., et al. (2004). Anti-inflammatory effects of total flavonoids from Phellodendron chinensis [J]. Journal of Shenyang Pharmaceutical University, 2004(04): 301-303.
[22] Shi, J. T., Zhang, X. B., Zhang, K., et al. (2020). Research progress on the role of three subtypes of MAPK signaling pathways in the development of intervertebral disc degeneration [J]. Shandong Medicine, 2020, 60(33): 112-115.